7-year Simulation of Clinical Outcomes In People With Type 2 Diabetes Treated With Insulin Glargine 300 U/mL vs 100 U/mL

Mapping Intimacies ◽

10.26226/morressier.617c37317c09fc044a975279 ◽

2021 ◽

Author(s):

Hui Shao ◽

Lizheng Shi ◽

Vivian Fonseca ◽

Abdul Jabbar Omar Alsaleh ◽

Jasvinder Gill ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Clinical Outcomes

Download Full-text

Real-World Clinical Outcomes of Type 2 Diabetes (T2D) Patients Switching From Insulin Glargine 100 U/mL (Gla-100) or Insulin Detemir (IDet) to Insulin Glargine 300 U/mL (Gla-300) or Insulin Degludec (IDeg)—DELIVER D+ Subgroup Analyses

Diabetes ◽

10.2337/db18-1057-p ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 1057-P

Author(s):

SEAN D. SULLIVAN ◽

TIMOTHY S. BAILEY ◽

RONAN ROUSSEL ◽

FANG L. ZHOU ◽

ZSOLT BOSNYAK ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Clinical Outcomes ◽

Insulin Detemir ◽

Insulin Degludec ◽

Subgroup Analyses

Download Full-text

Real-World Clinical Outcomes of Type 2 Diabetes (T2D) Patients Switching from Insulin Glargine 100 U/mL (Gla-100) or Insulin Detemir (IDet) to Insulin Glargine 300 U/mL (Gla-300) or Insulin Degludec (IDeg)—DELIVER D+

Diabetes ◽

10.2337/db18-1056-p ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 1056-P

Author(s):

SEAN D. SULLIVAN ◽

TIMOTHY S. BAILEY ◽

RONAN ROUSSEL ◽

FANG L. ZHOU ◽

ZSOLT BOSNYAK ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Clinical Outcomes ◽

Insulin Detemir ◽

Insulin Degludec

Download Full-text

Clinical Outcomes Using Long-Term Combination Therapy with Insulin Glargine and Exenatide in Patients with Type 2 Diabetes Mellitus

Endocrine Practice ◽

10.4158/ep11097.or ◽

2012 ◽

Vol 18 (1) ◽

pp. 17-25 ◽

Author(s):

Philip Levin ◽

James Mersey ◽

Steven Zhou ◽

Lee Bromberger

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Combination Therapy ◽

Insulin Glargine ◽

Clinical Outcomes

Download Full-text

PDB9 LONG-TERM CLINICAL OUTCOMES OF EXENATIDE ONCE-WEEKLY VERSUS INSULIN GLARGINE FOR THE TREATMENT OF TYPE 2 DIABETES PROJECTED USING THE CORE DIABETES MODEL

Value in Health ◽

10.1016/s1098-3015(11)72067-8 ◽

2010 ◽

Vol 13 (7) ◽

pp. A284-A285 ◽

Author(s):

L Timlin ◽

A Beaudet ◽

B Wilson ◽

D Bruhn ◽

KS Boye ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Clinical Outcomes ◽

The Core ◽

Download Full-text

Treatment Dosing Patterns and Clinical Outcomes for Patients with Type 2 Diabetes Starting or Switching to Treatment with Insulin Glargine (300 Units per Milliliter) in a Real-World Setting: A Retrospective Observational Study

Advances in Therapy ◽

10.1007/s12325-017-0651-3 ◽

2018 ◽

Vol 35 (1) ◽

pp. 43-55 ◽

Author(s):

Shaloo Gupta ◽

Hongwei Wang ◽

Neil Skolnik ◽

Liyue Tong ◽

Ryan M. Liebert ◽

...

Keyword(s):

Type 2 Diabetes ◽

Observational Study ◽

Insulin Glargine ◽

Clinical Outcomes ◽

Retrospective Observational Study ◽

Real World Setting ◽

Dosing Patterns

Download Full-text

Clinical Outcomes of Switching to Insulin Glargine 300 U/ml from Other Basal Insulins in People with Type 2 Diabetes in Italy: A Real-World Study

Diabetes Therapy ◽

10.1007/s13300-020-00902-1 ◽

2020 ◽

Vol 11 (10) ◽

pp. 2283-2298

Author(s):

Mauro Ragonese ◽

Monica Larosa ◽

Stefania Angotti ◽

Stefania Annese ◽

Laura Cruciani ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Clinical Outcomes ◽

Download Full-text

Clinical outcomes in real-world patients with type 2 diabetes switching from first- to second-generation basal insulin analogues: Comparative effectiveness of insulin glargine 300 units/mL and insulin degludec in the DELIVER D+ cohort study

Diabetes Obesity and Metabolism ◽

10.1111/dom.13345 ◽

2018 ◽

Vol 20 (9) ◽

pp. 2148-2158 ◽

Author(s):

Sean D. Sullivan ◽

Timothy S. Bailey ◽

Ronan Roussel ◽

Fang Liz Zhou ◽

Zsolt Bosnyak ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Insulin Glargine ◽

Clinical Outcomes ◽

Comparative Effectiveness ◽

Basal Insulin ◽

Insulin Analogues ◽

Insulin Degludec

Download Full-text

PDB22 ‘Real-World' Clinical Outcomes of Exenatide Bid Compared to Insulin Glargine in Patients with Type 2 Diabetes

Value in Health ◽

10.1016/j.jval.2011.08.1325 ◽

2011 ◽

Vol 14 (7) ◽

pp. A475

Author(s):

M. Pawaskar ◽

Q. Li ◽

B. Hoogwerf ◽

M.W. Reynolds ◽

D.E. Faries ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Clinical Outcomes ◽

Download Full-text

Comparative clinical outcomes of insulin degludec and insulin glargine 300 U/mL after switching from other basal insulins in real‐world patients with type 1 and type 2 diabetes

Journal of Diabetes Investigation ◽

10.1111/jdi.13559 ◽

2021 ◽

Author(s):

Junko Oya ◽

Tomoko Nakagami ◽

Yukiko Hasegawa ◽

Aki Katamine ◽

Yuichiro Kondo ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Clinical Outcomes ◽

Insulin Degludec

Download Full-text

PDB33 THE EFFICACY OF INSULIN GLARGINE COMPARED TO OTHER INJECTABLE THERAPIES-A META-ANALYSIS OF CLINICAL OUTCOMES IN INSULIN NAÏVE TYPE 2 DIABETES PATIENTS

Value in Health ◽

10.1016/s1098-3015(10)63303-7 ◽

2006 ◽

Vol 9 (6) ◽

pp. A234

Author(s):

K Pascoe ◽

CM McDonald-Everett ◽

P FitzGerald ◽

NR Yurgin ◽

K Secnik

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Clinical Outcomes ◽

Meta Analysis ◽

Diabetes Patients

Download Full-text